![]() | ![]() |
Formats:
|
||||||||||||||||||||
Copyright Salvaing et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited. The Enhancer of Trithorax and Polycomb Corto Interacts with Cyclin G in Drosophila 1Laboratoire de Biologie du Développement, UMR 7622, Centre National de la Recherche Scientifique (CNRS), Université Pierre et Marie Curie-Paris 6, Paris, France 2Institut für Genetik (240), Universität Hohenheim, Stuttgart, Germany Suzannah Rutherford, Academic Editor Fred Hutchinson Cancer Research Center, United States of America * To whom correspondence should be addressed. E-mail: Frederique.Peronnet/at/snv.jussieu.fr Conceived and designed the experiments: AP AN FP JS EM SB DM. Performed the experiments: AN JS EM SB DM. Analyzed the data: AP AN FP JS EM SB DM. Wrote the paper: AP FP. ¤Current address: UMR 1198, Ecole Nationale Vétérinaire d'Alfort (ENVA), Centre National de la Recherche Scientifique (CNRS), FRE 2857, Biologie du Développement et Reproduction, Jouy en Josas, France Received December 3, 2007; Accepted January 21, 2008. Abstract Background Polycomb (PcG) and trithorax (trxG) genes encode proteins involved in the maintenance of gene expression patterns, notably Hox genes, throughout development. PcG proteins are required for long-term gene repression whereas TrxG proteins are positive regulators that counteract PcG action. PcG and TrxG proteins form large complexes that bind chromatin at overlapping sites called Polycomb and Trithorax Response Elements (PRE/TRE). A third class of proteins, so-called “Enhancers of Trithorax and Polycomb” (ETP), interacts with either complexes, behaving sometimes as repressors and sometimes as activators. The role of ETP proteins is largely unknown. Methodology/Principal Findings In a two-hybrid screen, we identified Cyclin G (CycG) as a partner of the Drosophila ETP Corto. Inactivation of CycG by RNA interference highlights its essential role during development. We show here that Corto and CycG directly interact and bind to each other in embryos and S2 cells. Moreover, CycG is targeted to polytene chromosomes where it co-localizes at multiple sites with Corto and with the PcG factor Polyhomeotic (PH). We observed that corto is involved in maintaining Abd-B repression outside its normal expression domain in embryos. This could be achieved by association between Corto and CycG since both proteins bind the regulatory element iab-7 PRE and the promoter of the Abd-B gene. Conclusions/Significance Our results suggest that CycG could regulate the activity of Corto at chromatin and thus be involved in changing Corto from an Enhancer of TrxG into an Enhancer of PcG. Introduction In Drosophila, the Bithorax-complex (BX-C) contains the three Hox genes, Ultrabithorax (Ubx), abdominal-A (abd-A) and Abdominal-B (Abd-B), that specify the identities of the third thoracic segment (T3) and the eight abdominal segments (A1 to A8) [1]. These genes are expressed in spatially regulated patterns during embryonic development thanks to maternal, gap and pair-rule proteins. Their large cis-regulatory sequences are modular and allow parasegmental regulation. These sequences contain different classes of elements such as initiation elements that respond to early segmentation gene products, insulators and promoter targeting sequences (reviewed in [2]). Hox expression is maintained in the original pattern during later stages of development by the Polycomb-group (PcG) and trithorax-group (trxG) genes. In mutants of PcG or trxG genes, Hox patterns are established correctly but are not maintained. PcG proteins keep Hox genes silenced whereas TrxG proteins keep Hox genes activated thus counteracting PcG action [3], [4]. PcG and TrxG proteins are required for the maintenance of many gene expression patterns [5]. These maintenance proteins form heteromultimeric complexes that bind to chromatin and alter its structure. Current models propose that PcG complexes lead to compact, transcriptionally inactive chromatin, whereas TrxG complexes maintain chromatin in an open conformation that facilitates transcription. In Drosophila, several PcG and TrxG complexes have been purified so far: the Polycomb Repressive Complex 1 (PRC1), the Polycomb Repressive Complex 2 (PRC2), the PhoRC complex, the Pcl-PRC2 complex, the Trithorax Activating Complex 1 (TAC1) and the Brahma Complex (BRM) also called SWI/SNF complex. They are extremely large complexes that contain several proteins including chromatin modifying enzymes such as histone methyl-transferases, acetyl-transferases or deacetylases [5]–[8]. Although most PcG mutations suppress trxG mutations and vice versa, a large screen to identify modifiers of the trxG gene ash1 allowed isolation of enhancers that were previously identified as PcG [E(z), E(Pc), Asx, Scm, Psc and Su(z)2] [9]. These genes were then called Enhancers of Trithorax and Polycomb (ETPs). Further molecular data showed that some ETPs encode members of PRC complexes, such as E(Z), PSC or SCM, while some do not. Recently, Grimaud et al. proposed to reclassify these maintenance proteins, the label PcG being kept for members of PRC silencing complexes and the label TrxG for members of complexes that counteract PcG-mediated silencing [10]. A third class of proteins would be represented by PcG/TrxG DNA-binding recruiters or specific co-factors. We will keep here the term ETP for those maintenance proteins that play a dual role in PcG and TrxG functions without belonging to any PcG or TrxG complexes identified so far. The GAGA factor, Gaf, encoded by Trithorax-like (Trl), falls into this category. Indeed, it was first described as an activator of Hox genes, and later shown to play a role in the recruitment of PcG complexes without co-purifying with any PRC silencing complexes [11], [12]. The HMG protein DSP1 also meets the criteria to be an ETP: dsp1 mutants exhibit Hox gene loss-of-function phenotypes but DSP1 is also important for PcG recruitment to chromatin [13], [14]. We have previously shown that corto behaves genetically as an ETP. corto mutants present PcG as well as trxG phenotypes and enhance the phenotypes of some PcG, trxG and ETP mutants [15], [16]. Corto directly interacts with Gaf and DSP1 suggesting that ETPs are involved in collaborative processes [16], [17]. PcG, TrxG and ETP proteins bind DNA sequences called PRE/TRE that carry the information for the active or silent state of the gene they control (reviewed in [18]). Some PRE/TRE have been shown to maintain this transcriptional state throughout cellular divisions in absence of the initial activator or repressor [19], [20]. Despite massive efforts towards identification of PcG complex targets at genome scale [21]–[23], the mechanism by which the active or inactive state of PRE/TRE is conserved throughout several cell cycles remains still largely unknown. Many PcG and ETP mutants [Asx, corto, E(z), Pc, ph, Psc, Su(z)2, Trl] exhibit proliferation defects as well as chromosome condensation and segregation defects. This suggests that maintenance proteins play a general role in cell cycle control [24]–[28]. An attractive hypothesis is that ETPs are critical to maintain the correct association of PcG or TrxG complexes with chromatin during the cell cycle. In a two-hybrid screen using Corto as bait, we isolated Cyclin G (CycG), the Drosophila homologue of the mammalian Cyclin G1 and G2 (CycG1, CycG2). Vertebrate CycG1 is a transcriptional target of the tumor suppressor p53 [29], [30]. It is possibly involved in cell proliferation as it is overexpressed in certain cancer cells [31], [32]. However, CycG1 induces G2/M arrest and cell death in response to DNA damage [33]–[35]. Vertebrate CycG2 acts as a negative regulator of cell cycle, as shown by its high level in cells in which G1/S arrest has been induced by growth inhibitory signals [36], [37]. Here, we address the interactions between Corto and CycG both in vitro and in vivo. We show that CycG plays an essential role during development. Moreover, we show that CycG is targeted to many sites on polytene chromosomes where it co-localizes partially with Corto and with the PcG factor PH. As an ETP, corto maintains Abd-B repression in embryos. This could be achieved by association between Corto and CycG since both proteins bind to Abd-B regulatory elements, including the iab-7 PRE and the promoter. Results Drosophila Cyclin G interacts with Corto To further investigate Corto function, we performed a two-hybrid screen for potential Corto partners. As bait, we used the amino-terminal half of Corto containing a chromodomain [16]. A positive clone spanning almost the full-length CG11525 cDNA (positions 43 to 2263; Accession number NM 079870) encoding Cyclin G (CycG) was isolated. Subsequent two-hybrid assays showed that the chromodomain was not sufficient for interaction with CycG, and that CycG did not interact with the C-terminal half of Corto (figure 1A
Then, we performed GST pull-down assays. In vitro translated CycG protein was retained on GST-Corto beads containing the full-length protein and on GST-C1/324 beads containing the amino-terminal half of Corto, but not on the other GST-Corto fusion proteins tested (figure 1B CycG is an essential gene in flies The cyclin domain of Drosophila CycG is highly similar to the cyclin domains of vertebrate CycG1 and CycG2 (42% and 46% identity, respectively; figure 2A
Since no mutant of CG11525/CycG was available, we designed a P{UAS::dsCycG} construct to inactivate the gene by RNA-interference (RNAi) as described previously [39]. Tissue specific RNAi using various Gal4 driver lines resulted in a considerable downregulation of CycG activity as visualized by reduction of CycG mRNA and CycG protein levels (figure 3
Corto and CycG interact in vivo and co-localize at multiple sites on polytene chromosomes In vivo physical interactions between Corto and CycG were first analysed by co-immunoprecipitation of total embryonic protein extracts (figure 4A
Corto was previously shown to bind polytene chromosomes at multiple discrete loci suggesting that it might participate in the regulation of many genes [17]. Using CycG antisera, we first showed that CycG is ubiquitously expressed in embryos and larvae (not shown). To test whether interactions between Corto and CycG could take place on chromatin, we explored the binding of CycG to polytene chromosomes (figure 5A
We next asked whether Corto was essential for CycG recruitment to chromatin, and analysed CycG fixation on polytene chromosomes derived from corto07128/Df(3R)6–7 larvae. On the whole, no modification of the CycG binding pattern was observed (data not shown) suggesting that CycG recruitment does not depend on Corto. We have previously shown that Corto shares many sites on polytene chromosomes with PcG proteins ([16], [17] and figure 5C corto participates in the regulation of Abd-B expression in embryos Previous findings indicate that corto is involved in the regulation of Hox genes such as Scr or Ubx in larvae [15], [17]. Interestingly, in corto germinal clone embryos, Ubx was strongly down-regulated in parasegments (PS) 11–12 whereas normally expressed in more anterior segments ([15] and figure 6A
Corto and Cyclin G bind the iab-7 PRE and the promoter of Abd-B Co-localization of Corto and CycG proteins on polytene chromosomes raises the possibility that CycG and Corto belong to a complex that regulates Abd-B expression. To address this possibility, we investigated whether both proteins bind to Abd-B cis-regulatory sequences in embryos. We performed immunoprecipitation on formaldehyde cross-linked chromatin (XChIP) from 0–14h embryos. The co-immunoprecipitated DNA was amplified using primer pairs corresponding either to the promoter region of Abd-B (generating fragment p10), to the iab-7 PRE (generating fragments p9, p8 and p7) or to rp49 as a negative control. We found that Corto and CycG were both present on the promoter and on the iab-7 PRE (figure 7
Discussion We have identified Cyclin G as a new binding partner of the ETP Corto in Drosophila melanogaster. CycG inactivation leads to lethality showing that this gene is essential in flies. Mammalian genomes encode two G-type cyclins, CycG1 and CycG2, the first one being mainly nuclear whereas the second is mainly cytoplasmic [46]. Drosophila has a single homologue, however, it produces at least two different protein isoforms, only the larger being associated with chromatin. These isoforms could combine CycG1 and CycG2 functions. In Drosophila, large scale two-hybrid screens suggested binding of CycG to various Cyclin-Dependent Kinases (CDK) (Cdc2 and Cdk4) [47], [48]. Corto and CycG interact in vitro as well as in vivo and form a complex in embryos and presumably also on chromatin. Moreover, Corto interacts with the amino-terminal domain of CycG, which is compatible with the simultaneous binding of CDK and cell-cycle control function of CycG. Requirement of PcG, trxG and ETP genes in cell-cycle control has already been shown in Drosophila [49], [50]. Interestingly, PcG and trxG genes are also involved in self-renewal and proliferation of hematopoietic stem cells in vertebrates [51], [52]. One way they might control cell proliferation is by an epigenetic regulation of genes involved in cell cycle and cell proliferation. Indeed, homologues of Drosophila E(z) and Brm participate in the transcriptional regulation of Cyclin A and E in vertebrates, and in Drosophila, Cyclin A is a PcG target [53]–[55]. Alternatively, PcG, TrxG or ETP proteins may interact directly with cell cycle regulatory proteins. Indeed, it has been shown that Brm interacts with Cyclin E, that Mel-18, a human homologue of Posterior Sex Combs, interacts with Cyclin D2 possibly blocking its interaction with Cdks [56], [57] and we show here that the ETP Corto interacts with CycG. These interactions reveal a potential role for these maintenance proteins in regulating the cell cycle independently of transcriptional regulation. This could be a widespread mechanism by which PcG, TrxG and ETP coordinate the chromatin activity status. CycG and Corto co-localize on many sites on polytene chromosomes suggesting that they may have regulated associations. Our data show that Corto represses Abd-B in embryos and although we were not able to test the role of CycG in regulating Abd-B expression in embryos, we observed that both Corto and CycG bind the iab-7 PRE and the promoter of Abd-B suggesting that they could cooperate in this function. Nevertheless, neither Corto nor CycG were detected on the BX-C locus in salivary glands suggesting that they regulate Abd-B in a tissue-specific manner. The role of the CycG-Corto interaction needs to be further investigated. CycG could regulate Corto activity directly on chromatin by recruiting other factors like kinases or phosphatases thus modifying the phosphorylation status of Corto itself, of histones or other proteins at PRE/TRE and promoters. It has been shown that binding of the PcG protein Bmi1 to chromatin correlates with its phosphorylation status [58], [59]. It will be interesting to investigate whether Corto and CycG bind the iab-7 PRE and promoter of Abd-B simultaneously, to examine their phosphorylation status when bound to chromatin, and to determine if their presence correlates with Abd-B transcriptional activity. One interesting possibility would be that CycG is involved in changing Corto from an Enhancer of TrxG into an Enhancer of PcG. Materials and Methods Drosophila strains and genetics Details on Drosophila strains can be found in Flybase [60]. corto420 and corto07128 are strong hypomorphic alleles; corto420/TM6B was a gift from Roland Rosset [27]. corto-deficient germline clones were obtained as previously described [15]. Other strains were obtained from either Bloomington or Kyoto Drosophila stock centers. CycG transgenic lines were established by standard P-element mediated transformation. Plasmid constructs Corto-GST fusions and pBS-Corto were previously described [16]. The pJG-CycG plasmid served for PCR amplification of full-length or truncated forms of CycG that were subsequently cloned into pGEX4T-1. Full length cDNAs were subcloned into pENTR/D-TOPO® and transferred into Gateway™ vectors: corto into pAWF to obtain pAct::Corto-Flag, and CycG into pAMW to obtain pAct::Myc-CycG [61]. P{UAS::CycG} was constructed by cloning the entire cDNA as EcoRI/XhoI fragment into pUAST [62]. UAS::dsCycG was constructed as outlined before [39]. About 600 nucleotide coding sequence (codons 72 to 268) was chosen to prepare the RNAi-construct. This segment shows only limited identity to other Drosophila genes and none of them conforms to an optimal siRNA. Two possible “Off-Targets” were found, LvpL encoding a larval protein with a predicted role in glucose metabolism and CG15639 encoding an unknown product. In both cases, 21 nucleotides are identical with a GC content of 55–58% instead of the optimal 43–53% [63]. Cloning details are available upon request. Antibodies Corto and Polyhomeotic (PH) antibodies were used as described previously [17]. Antibodies against Abd-B (clone 1A2E9) were obtained from the Developmental Studies Hybridoma Bank. Polyclonal antibodies against CycG were raised against the N-terminal 276 amino-acids of CycG fused to maltose binding protein in rabbit, rat and guinea pig. Their specificity was checked on CycG protein generated by in vitro transcription/translation. Monoclonal anti-Flag M2 and anti-HA was from Sigma (F-3165, H-3663) and anti-Myc clone 9E10 from Santa-Cruz Biotechnology. Histology Antibody staining of embryos and larvae was performed using rabbit anti-CycG (1 40) or mouse monoclonal anti-Abd-B (1 10) [64]. Co-immunostaining of polytene chromosomes was performed with rabbit anti-Corto (1 40) and guinea-pig anti-CycG (1 40) according to [16]. Secondary antibodies (Alexa Fluor® 594 goat anti-rabbit IgG and Alexa Fluor® 488 goat anti-guinea pig; Molecular Probes) were used at a 1 1000 dilution.Protein-protein interactions A two-hybrid screen was performed using pEG-C1/324 that encodes amino-acids 1 to 324 of Corto as bait [16]. The embryonic RFLY1 library [65] was transformed into EGY48SHΔSpe [MATα his3, trp1, ura3, LexAop(x6)-LEU2] containing the bait. In vitro transcription/translation and GST pull-down assays were performed as described [16]. For co-immunoprecipitations, 1 g of 0–14 h w1118 embryos were homogenized in RIPA buffer (50 mM Tris pH 7.5, 150 mM NaCl, 0.5% NP40, 0.1% SDS, 1 mM PMSF) with protease inhibitors (Roche Diagnostics). 500 µl of total extract (about 1 mg) were pre-cleared with protein A plus protein G agarose beads (for polyclonal antibody IP) or protein G beads (for monoclonal anti-Myc, anti-Flag or anti-HA). Input was 20 µl of this mixture. Incubation was with 10 µl of either rabbit pre-immune or Corto antiserum, mouse anti-Flag, anti-Myc or anti-HA overnight at 4°C. The appropriate beads were added and further incubated for 2 h at 4°C. The supernatant was kept; the beads were washed five times with RIPA buffer and finally resuspended in 40 µl of Laemmli buffer. 20 µl of input (4%), 20 µl of supernatant and half of the beads (20 µl) were loaded. Immunoprecipitates were detected with respective antisera developed in rat. Drosophila S2 cells were cultivated at 25°C in Schneider medium supplemented with 10% fetal calf serum and antibiotics. Cells were transfected using Effecten® transfection reagent according to the manufacturer (Qiagen). Commonly, 2×106 cells were transfected with 1 µg of each DNA. Cells were collected after 48 h of incubation and homogenized in 500 µl of RIPA buffer. Immunoprecipitation of crosslinked chromatin (XChIP) Chromatin from 0–14 h embryos was formaldehyde cross-linked and immunoprecipitated as described [66] using rabbit anti-Corto (1 20), rabbit anti-CycG (1 20), guinea-pig anti-CycG (1:20) or rabbit pre-immune sera (mock) (1 20). Three independent immunoprecipitations were performed and further analysed. The precipitated DNA was dissolved in 100 µl of TE [10 mM Tris (pH 8.0), 1 mM EDTA] and 1 µl was used per PCR reaction. Three primer pairs spanning the iab-7 PRE (p7, p8, p9) and one primer pair from the promoter region of Abd-B (p10) were used [42], [45]. rp49 was used as negative control (primers 5′ CCC AAG ATC GTG AAG AAG CG 3′ and 5′ AGA TAC TGT CCC TTG AAG CG 3′). PCR schemes were as follows: 94°C for 3 minutes; 94°C for one minute, 45°C (p7, p9), 50°C (p8, p10, rp49) for one minute, 72°C for one minute, 36 cycles; 72°C for 10 minutes. 5 µl samples were taken every 2 cycles from the 29th to the 35th cycle to determine the linear range of amplification. PCR products were quantified using ImageJ and results of three independent experiments were normalized against the mock immunoprecipitation.Acknowledgments We thank Dr S. Celniker, R. Finley, T.D. Murphy, the Developmental Studies Hybridoma Bank and the Bloomington stock center for reagents, Dr J. Deutsch, J-M. Gibert, N. Randsholt and J. Szawinski for critically reading of the manuscript, and V. Ribeiro and N. Salmon for excellent technical assistance. Footnotes Competing Interests: The authors have declared that no competing interests exist. Funding: This work was supported by CNRS and UPMC and by grant 4492 from ARC to F.P. J.S. was partly supported by a scholarship from ARC. References 1. Lewis EB. A gene complex controlling segmentation in Drosophila. Nature. 1978;276:565–570. [PubMed] 2. Maeda RK, Karch F. The ABC of the BX-C: the bithorax complex explained. Development. 2006;133:1413–1422. [PubMed] 3. Ingham PW. A clonal analysis of the requirement for the trithorax gene in the diversification of segments in Drosophila. J Embryol Exp Morphol. 1985;89:349–365. [PubMed] 4. Moehrle A, Paro R. Spreading the silence: epigenetic transcriptional regulation during Drosophila development. Dev Genet. 1994;15:478–484. [PubMed] 5. Brock HW, Fisher CL. Maintenance of gene expression patterns. Dev Dyn. 2005;232:633–655. [PubMed] 6. Ringrose L, Paro R. Epigenetic regulation of cellular memory by the Polycomb and Trithorax group proteins. Annu Rev Genet. 2004;38:413–443. [PubMed] 7. Schuettengruber B, Chourrout D, Vervoort M, Leblanc B, Cavalli G. Genome regulation by polycomb and trithorax proteins. Cell. 2007;128:735–745. [PubMed] 8. Nekrasov M, Klymenko T, Fraterman S, Papp B, Oktaba K, et al. Pcl-PRC2 is needed to generate high levels of H3-K27 trimethylation at Polycomb target genes. Embo J. 2007;26:4078–4088. [PubMed] 9. Gildea JJ, Lopez R, Shearn A. A screen for new trithorax group genes identified little imaginal discs, the Drosophila melanogaster homologue of human retinoblastoma binding protein 2. Genetics. 2000;156:645–663. [PubMed] 10. Grimaud C, Negre N, Cavalli G. From genetics to epigenetics: the tale of Polycomb group and trithorax group genes. Chromosome Res. 2006;14:363–375. [PubMed] 11. Farkas G, Gausz J, Galloni M, Reuter G, Gyurkovics H, et al. The Trithorax-like gene encodes the Drosophila GAGA factor. Nature. 1994;371:806–808. [PubMed] 12. Poux S, Melfi R, Pirrotta V. Establishment of Polycomb silencing requires a transient interaction between PC and ESC. Genes Dev. 2001;15:2509–2514. [PubMed] 13. Decoville M, Giacomello E, Leng M, Locker D. DSP1, an HMG-like protein, is involved in the regulation of homeotic genes. Genetics. 2001;157:237–244. [PubMed] 14. Dejardin J, Rappailles A, Cuvier O, Grimaud C, Decoville M, et al. Recruitment of Drosophila Polycomb group proteins to chromatin by DSP1. Nature. 2005;434:533–538. [PubMed] 15. Lopez A, Higuet D, Rosset R, Deutsch J, Peronnet F. corto genetically interacts with Pc-G and trx-G genes and maintains the anterior boundary of Ultrabithorax expression in Drosophila larvae. Mol Genet Genomics. 2001;266:572–583. [PubMed] 16. Salvaing J, Lopez A, Boivin A, Deutsch JS, Peronnet F. The Drosophila Corto protein interacts with Polycomb-group proteins and the GAGA factor. Nucleic Acids Res. 2003;31:2873–2882. [PubMed] 17. Salvaing J, Decoville M, Mouchel-Vielh E, Bussiere M, Daulny A, et al. Corto and DSP1 interact and bind to a maintenance element of the Scr Hox gene: understanding the role of Enhancers of trithorax and Polycomb. BMC Biol. 2006;4:9. [PubMed] 18. Ringrose L, Paro R. Polycomb/Trithorax response elements and epigenetic memory of cell identity. Development. 2007;134:223–232. [PubMed] 19. Cavalli G, Paro R. The Drosophila Fab-7 chromosomal element conveys epigenetic inheritance during mitosis and meiosis. Cell. 1998;93:505–518. [PubMed] 20. Maurange C, Paro R. A cellular memory module conveys epigenetic inheritance of hedgehog expression during Drosophila wing imaginal disc development. Genes Dev. 2002;16:2672–2683. [PubMed] 21. Negre N, Hennetin J, Sun LV, Lavrov S, Bellis M, et al. Chromosomal distribution of PcG proteins during Drosophila development. PLoS Biol. 2006;4:e170. [PubMed] 22. Schwartz YB, Kahn TG, Nix DA, Li XY, Bourgon R, et al. Genome-wide analysis of Polycomb targets in Drosophila melanogaster. Nat Genet. 2006;38:700–705. [PubMed] 23. Tolhuis B, Muijrers I, de Wit E, Teunissen H, Talhout W, et al. Genome-wide profiling of PRC1 and PRC2 Polycomb chromatin binding in Drosophila melanogaster. Nat Genet. 2006;38:694–699. [PubMed] 24. Gatti M, Baker BS. Genes controlling essential cell-cycle functions in Drosophila melanogaster. Genes Dev. 1989;3:438–453. [PubMed] 25. Rastelli L, Chan CS, Pirrotta V. Related chromosome binding sites for zeste, suppressors of zeste and Polycomb group proteins in Drosophila and their dependence on Enhancer of zeste function. Embo J. 1993;12:1513–1522. [PubMed] 26. Bhat KM, Farkas G, Karch F, Gyurkovics H, Gausz J, et al. The GAGA factor is required in the early Drosophila embryo not only for transcriptional regulation but also for nuclear division. Development. 1996;122:1113–1124. [PubMed] 27. Kodjabachian L, Delaage M, Maurel C, Miassod R, Jacq B, et al. Mutations in ccf, a novel Drosophila gene encoding a chromosomal factor, affect progression through mitosis and interact with Pc-G mutations. Embo J. 1998;17:1063–1075. [PubMed] 28. O'Dor E, Beck SA, Brock HW. Polycomb group mutants exhibit mitotic defects in syncytial cell cycles of Drosophila embryos. Dev Biol. 2006;290:312–322. [PubMed] 29. Tamura K, Kanaoka Y, Jinno S, Nagata A, Ogiso Y, et al. Cyclin G: a new mammalian cyclin with homology to fission yeast Cig1. Oncogene. 1993;8:2113–2118. [PubMed] 30. Okamoto K, Beach D. Cyclin G is a transcriptional target of the p53 tumor suppressor protein. Embo J. 1994;13:4816–4822. [PubMed] 31. Reimer CL, Borras AM, Kurdistani SK, Garreau JR, Chung M, et al. Altered regulation of cyclin G in human breast cancer and its specific localization at replication foci in response to DNA damage in p53+/+ cells. J Biol Chem. 1999;274:11022–11029. [PubMed] 32. Baek WK, Kim D, Jung N, Yi YW, Kim JM, et al. Increased expression of cyclin G1 in leiomyoma compared with normal myometrium. Am J Obstet Gynecol. 2003;188:634–639. [PubMed] 33. Okamoto K, Prives C. A role of cyclin G in the process of apoptosis. Oncogene. 1999;18:4606–4615. [PubMed] 34. Kimura SH, Ikawa M, Ito A, Okabe M, Nojima H. Cyclin G1 is involved in G2/M arrest in response to DNA damage and in growth control after damage recovery. Oncogene. 2001;20:3290–3300. [PubMed] 35. Seo HR, Lee DH, Lee HJ, Baek M, Bae S, et al. Cyclin G1 overcomes radiation-induced G2 arrest and increases cell death through transcriptional activation of cyclin B1. Cell Death Differ. 2006;13:1475–1484. [PubMed] 36. Bates S, Rowan S, Vousden KH. Characterisation of human cyclin G1 and G2: DNA damage inducible genes. Oncogene. 1996;13:1103–1109. [PubMed] 37. Bennin DA, Don AS, Brake T, McKenzie JL, Rosenbaum H, et al. Cyclin G2 associates with protein phosphatase 2A catalytic and regulatory B' subunits in active complexes and induces nuclear aberrations and a G1/S phase cell cycle arrest. J Biol Chem. 2002;277:27449–27467. [PubMed] 38. Salamov AA, Nishikawa T, Swindells MB. Assessing protein coding region integrity in cDNA sequencing projects. Bioinformatics. 1998;14:384–390. [PubMed] 39. Nagel AC, Maier D, Preiss A. Green fluorescent protein as a convenient and versatile marker for studies on functional genomics in Drosophila. Dev Genes Evol. 2002;212:93–98. [PubMed] 40. Celniker SE, Keelan DJ, Lewis EB. The molecular genetics of the bithorax complex of Drosophila: characterization of the products of the Abdominal-B domain. Genes Dev. 1989;3:1424–1436. [PubMed] 41. Delorenzi M, Bienz M. Expression of Abdominal-B homeoproteins in Drosophila embryos. Development. 1990;108:323–329. [PubMed] 42. Breiling A, O'Neill LP, D'Eliseo D, Turner BM, Orlando V. Epigenome changes in active and inactive polycomb-group-controlled regions. EMBO Rep. 2004;5:976–982. [PubMed] 43. Dejardin J, Cavalli G. Chromatin inheritance upon Zeste-mediated Brahma recruitment at a minimal cellular memory module. Embo J. 2004;23:857–868. [PubMed] 44. Martin CH, Mayeda CA, Davis CA, Ericsson CL, Knafels JD, et al. Complete sequence of the bithorax complex of Drosophila. Proc Natl Acad Sci U S A. 1995;92:8398–8402. [PubMed] 45. Breiling A, Turner BM, Bianchi ME, Orlando V. General transcription factors bind promoters repressed by Polycomb group proteins. Nature. 2001;412:651–655. [PubMed] 46. Horne MC, Goolsby GL, Donaldson KL, Tran D, Neubauer M, et al. Cyclin G1 and cyclin G2 comprise a new family of cyclins with contrasting tissue-specific and cell cycle-regulated expression. J Biol Chem. 1996;271:6050–6061. [PubMed] 47. Giot L, Bader JS, Brouwer C, Chaudhuri A, Kuang B, et al. A protein interaction map of Drosophila melanogaster. Science. 2003;302:1727–1736. [PubMed] 48. Stanyon CA, Liu G, Mangiola BA, Patel N, Giot L, et al. A Drosophila protein-interaction map centered on cell-cycle regulators. Genome Biol. 2004;5:R96. [PubMed] 49. Remillieux-Leschelle N, Santamaria P, Randsholt NB. Regulation of larval hematopoiesis in Drosophila melanogaster: a role for the multi sex combs gene. Genetics. 2002;162:1259–1274. [PubMed] 50. Narbonne K, Besse F, Brissard-Zahraoui J, Pret AM, Busson D. polyhomeotic is required for somatic cell proliferation and differentiation during ovarian follicle formation in Drosophila. Development. 2004;131:1389–1400. [PubMed] 51. Lessard J, Sauvageau G. Polycomb group genes as epigenetic regulators of normal and leukemic hemopoiesis. Exp Hematol. 2003;31:567–585. [PubMed] 52. Lee TI, Jenner RG, Boyer LA, Guenther MG, Levine SS, et al. Control of developmental regulators by Polycomb in human embryonic stem cells. Cell. 2006;125:301–313. [PubMed] 53. Coisy M, Roure V, Ribot M, Philips A, Muchardt C, et al. Cyclin A repression in quiescent cells is associated with chromatin remodeling of its promoter and requires Brahma/SNF2alpha. Mol Cell. 2004;15:43–56. [PubMed] 54. Tonini T, Bagella L, D'Andrilli G, Claudio PP, Giordano A. Ezh2 reduces the ability of HDAC1-dependent pRb2/p130 transcriptional repression of cyclin A. Oncogene. 2004;23:4930–4937. [PubMed] 55. Martinez AM, Colomb S, Dejardin J, Bantignies F, Cavalli G. Polycomb group-dependent Cyclin A repression in Drosophila. Genes Dev. 2006;20:501–513. [PubMed] 56. Brumby AM, Zraly CB, Horsfield JA, Secombe J, Saint R, et al. Drosophila cyclin E interacts with components of the Brahma complex. Embo J. 2002;21:3377–3389. [PubMed] 57. Chun T, Rho SB, Byun HJ, Lee JY, Kong G. The polycomb group gene product Mel-18 interacts with cyclin D2 and modulates its activity. FEBS Lett. 2005;579:5275–5280. [PubMed] 58. Voncken JW, Schweizer D, Aagaard L, Sattler L, Jantsch MF, et al. Chromatin-association of the Polycomb group protein BMI1 is cell cycle-regulated and correlates with its phosphorylation status. J Cell Sci. 1999;112 ( Pt 24):4627–4639. [PubMed] 59. Voncken JW, Niessen H, Neufeld B, Rennefahrt U, Dahlmans V, et al. MAPKAP kinase 3pK phosphorylates and regulates chromatin association of the polycomb group protein Bmi1. J Biol Chem. 2005;280:5178–5187. [PubMed] 60. Crosby MA, Goodman JL, Strelets VB, Zhang P, Gelbart WM. FlyBase: genomes by the dozen. Nucleic Acids Res. 2007;35:D486–491. [PubMed] 61. Huynh CQ, Zieler H. Construction of modular and versatile plasmid vectors for the high-level expression of single or multiple genes in insects and insect cell lines. J Mol Biol. 1999;288:13–20. [PubMed] 62. Brand AH, Perrimon N. Targeted gene expression as a means of altering cell fates and generating dominant phenotypes. Development. 1993;118:401–415. [PubMed] 63. Reynolds A, Leake D, Boese Q, Scaringe S, Marshall WS, et al. Rational siRNA design for RNA interference. Nat Biotechnol. 2004;22:326–330. [PubMed] 64. LaJeunesse D, Shearn A. E(z): a polycomb group gene or a trithorax group gene? Development. 1996;122:2189–2197. [PubMed] 65. Finley RL, Jr., Thomas BJ, Zipursky SL, Brent R. Isolation of Drosophila cyclin D, a protein expressed in the morphogenetic furrow before entry into S phase. Proc Natl Acad Sci U S A. 1996;93:3011–3015. [PubMed] 66. Cavalli G, Orlando V, Paro R. Mapping DNA target sites of chromatin-associated proteins by formaldehyde cross-linking in Drosophila embryos. In: Bickmore WA, editor. Chromosome Structural Analysis: A Practical Approach: UK: Oxford University Press; 1999. pp. 20–37. |
PubMed related articles
Your browsing activity is empty. Activity recording is turned off. |
|||||||||||||||||||
Nature. 1978 Dec 7; 276(5688):565-70.
[Nature. 1978]Development. 2006 Apr; 133(8):1413-22.
[Development. 2006]J Embryol Exp Morphol. 1985 Oct; 89():349-65.
[J Embryol Exp Morphol. 1985]Dev Genet. 1994; 15(6):478-84.
[Dev Genet. 1994]Dev Dyn. 2005 Mar; 232(3):633-55.
[Dev Dyn. 2005]EMBO J. 2007 Sep 19; 26(18):4078-88.
[EMBO J. 2007]Genetics. 2000 Oct; 156(2):645-63.
[Genetics. 2000]Chromosome Res. 2006; 14(4):363-75.
[Chromosome Res. 2006]Nature. 1994 Oct 27; 371(6500):806-8.
[Nature. 1994]Genes Dev. 2001 Oct 1; 15(19):2509-14.
[Genes Dev. 2001]Genetics. 2001 Jan; 157(1):237-44.
[Genetics. 2001]Development. 2007 Jan; 134(2):223-32.
[Development. 2007]Cell. 1998 May 15; 93(4):505-18.
[Cell. 1998]Genes Dev. 2002 Oct 15; 16(20):2672-83.
[Genes Dev. 2002]PLoS Biol. 2006 Jun; 4(6):e170.
[PLoS Biol. 2006]Nat Genet. 2006 Jun; 38(6):694-9.
[Nat Genet. 2006]Oncogene. 1993 Aug; 8(8):2113-8.
[Oncogene. 1993]EMBO J. 1994 Oct 17; 13(20):4816-22.
[EMBO J. 1994]J Biol Chem. 1999 Apr 16; 274(16):11022-9.
[J Biol Chem. 1999]Am J Obstet Gynecol. 2003 Mar; 188(3):634-9.
[Am J Obstet Gynecol. 2003]Oncogene. 1999 Aug 12; 18(32):4606-15.
[Oncogene. 1999]Nucleic Acids Res. 2003 Jun 1; 31(11):2873-82.
[Nucleic Acids Res. 2003]Bioinformatics. 1998 Jun; 14(5):384-90.
[Bioinformatics. 1998]Dev Genes Evol. 2002 Mar; 212(2):93-8.
[Dev Genes Evol. 2002]BMC Biol. 2006 Apr 14; 4():9.
[BMC Biol. 2006]Nucleic Acids Res. 2003 Jun 1; 31(11):2873-82.
[Nucleic Acids Res. 2003]BMC Biol. 2006 Apr 14; 4():9.
[BMC Biol. 2006]Mol Genet Genomics. 2001 Dec; 266(4):572-83.
[Mol Genet Genomics. 2001]BMC Biol. 2006 Apr 14; 4():9.
[BMC Biol. 2006]Genes Dev. 1989 Sep; 3(9):1424-36.
[Genes Dev. 1989]Development. 1990 Feb; 108(2):323-9.
[Development. 1990]EMBO Rep. 2004 Oct; 5(10):976-82.
[EMBO Rep. 2004]EMBO J. 2004 Feb 25; 23(4):857-68.
[EMBO J. 2004]Proc Natl Acad Sci U S A. 1995 Aug 29; 92(18):8398-402.
[Proc Natl Acad Sci U S A. 1995]EMBO Rep. 2004 Oct; 5(10):976-82.
[EMBO Rep. 2004]Nature. 2001 Aug 9; 412(6847):651-5.
[Nature. 2001]J Biol Chem. 1996 Mar 15; 271(11):6050-61.
[J Biol Chem. 1996]Science. 2003 Dec 5; 302(5651):1727-36.
[Science. 2003]Genome Biol. 2004; 5(12):R96.
[Genome Biol. 2004]Genetics. 2002 Nov; 162(3):1259-74.
[Genetics. 2002]Development. 2004 Mar; 131(6):1389-400.
[Development. 2004]Exp Hematol. 2003 Jul; 31(7):567-85.
[Exp Hematol. 2003]Cell. 2006 Apr 21; 125(2):301-13.
[Cell. 2006]Mol Cell. 2004 Jul 2; 15(1):43-56.
[Mol Cell. 2004]J Cell Sci. 1999 Dec; 112 ( Pt 24)():4627-39.
[J Cell Sci. 1999]J Biol Chem. 2005 Feb 18; 280(7):5178-87.
[J Biol Chem. 2005]Nucleic Acids Res. 2007 Jan; 35(Database issue):D486-91.
[Nucleic Acids Res. 2007]EMBO J. 1998 Feb 16; 17(4):1063-75.
[EMBO J. 1998]Mol Genet Genomics. 2001 Dec; 266(4):572-83.
[Mol Genet Genomics. 2001]Nucleic Acids Res. 2003 Jun 1; 31(11):2873-82.
[Nucleic Acids Res. 2003]J Mol Biol. 1999 Apr 23; 288(1):13-20.
[J Mol Biol. 1999]Development. 1993 Jun; 118(2):401-15.
[Development. 1993]Dev Genes Evol. 2002 Mar; 212(2):93-8.
[Dev Genes Evol. 2002]Nat Biotechnol. 2004 Mar; 22(3):326-30.
[Nat Biotechnol. 2004]BMC Biol. 2006 Apr 14; 4():9.
[BMC Biol. 2006]Development. 1996 Jul; 122(7):2189-97.
[Development. 1996]Nucleic Acids Res. 2003 Jun 1; 31(11):2873-82.
[Nucleic Acids Res. 2003]Nucleic Acids Res. 2003 Jun 1; 31(11):2873-82.
[Nucleic Acids Res. 2003]Proc Natl Acad Sci U S A. 1996 Apr 2; 93(7):3011-5.
[Proc Natl Acad Sci U S A. 1996]EMBO Rep. 2004 Oct; 5(10):976-82.
[EMBO Rep. 2004]Nature. 2001 Aug 9; 412(6847):651-5.
[Nature. 2001]